Trending...
- Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
- Defense & Space Strategy Strengthens as New Leadership Builds on NASA Results and Expanding Multi-Orbit Opportunities for Ascent Solar Technologies
- Tacoma: Northbound I-705 Stadium Way Off-Ramp to Close at Noon Today for Emergency Repairs
With an innovative move to combat semiconductor lead times, component availability issues, and the use of unreliable automotive and COTS parts in space, VORAGO introduces a readily available rad-tolerant Arm® Cortex-M0, VA10805, with TID protection up to 300 krad(Si) for the emerging space market.
AUSTIN, Texas - Washingtoner -- VORAGO Technologies (https://voragotech.com) today announced a product portfolio expansion to include a new radiation-tolerant Arm® Cortex-M0 MCU, VA10805, as a cost-competitive and high reliability solution for LEO, New Space, SmallSat and CubeSat markets.
"As commercialization of space continues to grow, so does the need for reliable, affordable, and immediately available component options for cost-sensitive aerospace projects and missions. VORAGO is proud to be a part of that venture. In recent times, the semiconductor industry has experienced major supply shortages and extensive lead times. Our team at VORAGO recognized this problem and have provided a solution. We are excited to bring to the market our immediately available radiation-tolerant, cost-effective VA10805. – Dr. Hannah Moore, Sr. Manager, Product Management, VORAGO Technologies
More on Washingtoner
Created with VORAGO's patented HARDSIL® technology specifically to provide competitive radiation protection for space applications, the VA10805 provides significantly more total ionizing dose protection than competing products. The VA10805 is an ideal solution for LEO missions, CubeSat and SmallSat constellations in need of immediately available radiation-tolerant microcontroller capabilities.
VORAGO's VA10805 includes the following features and benefits:
"As commercialization of space continues to grow, so does the need for reliable, affordable, and immediately available component options for cost-sensitive aerospace projects and missions. VORAGO is proud to be a part of that venture. In recent times, the semiconductor industry has experienced major supply shortages and extensive lead times. Our team at VORAGO recognized this problem and have provided a solution. We are excited to bring to the market our immediately available radiation-tolerant, cost-effective VA10805. – Dr. Hannah Moore, Sr. Manager, Product Management, VORAGO Technologies
More on Washingtoner
- Boston Industrial Solutions Introduces Personalized Printing Training
- Century Fasteners de Mexico Exhibiting at the 2026 Automotive & Aerospace Nearshoring Summit
- Spokane: Funding Available for Tourism and Culture Investment Grants
- Retell AI White Label Platform for Agencies Launched by VoiceAIWrapper, With Branded Client Portals and No Per-Minute Markup
- FOCUS Names Mark Phillips Senior Vice President of Business Development
Created with VORAGO's patented HARDSIL® technology specifically to provide competitive radiation protection for space applications, the VA10805 provides significantly more total ionizing dose protection than competing products. The VA10805 is an ideal solution for LEO missions, CubeSat and SmallSat constellations in need of immediately available radiation-tolerant microcontroller capabilities.
VORAGO's VA10805 includes the following features and benefits:
- 50MHz Arm® Cortex® - M0
- Latch-up immunity with HARDSIL® Hardened by Process Technology
- Total Ionizing Dose (TID): 300 krad (Si)
- 23KB Data and 128KB Program Memory
- 1KB One Time Programmable Configuration Memory (OTP)
- Broad range of communication interfaces (I2C, UART, SPI)
- 24 Counter/Timers with Extensive Hardware/Software Triggering
- 56 Multiplexed GPIOs
- Operating temperature range: -55 to 125°C
- Easy-to-design development kit, with exceptional support and service offerings available
- To learn more or request a datasheet, visit VORAGO's Product Page.
Source: VORAGO Technologies
Filed Under: Technology
0 Comments
Latest on Washingtoner
- Spokane: Flags Lowered for Mayor Tim Verzal
- Lawsuit Alleges American Deli Food Caused Severe Illness, Acute Kidney Failure, And Eight-day Hospitalization
- FBI/DoW plot uncovered to hurt Trump/Vance through encouraged "widespread" cybersecurity breaches and racketeering theft of $80m in USDA payments
- City of Tacoma Aligns Parking Rates and Facilities for Downtown Parking Network Effective October 13
- Bettingbladet releases H1 2026 report on the Swedish online gambling market
- Garage door installation or repair in Minnesota? Which makes more sense for your family?
- Tacoma: Application for 2027 Community Arts Projects Funding Now Available
- Haven Treatment Center Now In-Network Partnership with ComPsych, Expanding Access to Youth Health
- Tacoma: OMWBE Certification 201 Workshop on September 28
- Super Rooter Expands to 190 Plumbing, Sewer, and Drain Service Locations Across the United States
- European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
- VICTURY Sports Announces Formation of Youth Sports League Built on the Official, Patented, and Award-Winning Keepy Uppy® Ball
- Congressman Chuck Edwards (NC-11) Presents ReadyCommunities Partnership 2026 National Service Award to Local Businessman / US Air Force Veteran
- Cress Creeks Farm Opens Fall Corn Maze and Baby Lamb Hayride Experience in Ellijay, Georgia
- Allstream Energy Partners Nominated in Multiple Categories for Fast Company's Best Workplaces for Innovators
- Pebble Photo Booths Brings Modern Photo Experiences to Vancouver, Washington
- Spokane: Flags at Half-Staff in Remembrance of 9/11 Victims
- Haven Treatment Center Now In-Network with First Choice, Expanding Access to Youth Health
- Kerri Lawless Introduces New Home-Selling Option for Local Homeowners
- FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)